You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.
In Nature this week: athletes' gut microbiomes, nanopore metagenomic sequencing approach to diagnosing infectious diseases, and more.
Participants aim to use predictive modeling to better understand epigenetic mechanisms, while encouraging the development of new technologies and therapies.
UK clinicians are to begin a trial using Oxford Nanopore's MinION to diagnose pneumonia, according to the Telegraph.
A quarter of the polar alga genome harbors highly divergent alleles, an international research team reported.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.